Oramed Pharmaceuticals Inc. (ORMP) stock
ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.89+0.02 (+0.52%)
Close on Nov 18, 2026Market cap $161.81MP/E 0.9Yield 6.43%
Oramed Pharmaceuticals shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Oramed Pharmaceuticals's shares outstanding was 43M at Jun 30, 2026. For fiscal 2025 it was 42M, up 3.8% from the year before. Over ten years it grew 16.5% a year on average. The highest annual figure on record is 42M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 42M | +3.8% |
| FY2024 | Dec 31, 2024 | 41M | +0.7% |
| FY2023 | Dec 31, 2023 | 41M | +42.5% |
| FY2021 | Aug 31, 2021 | 28M | +38.7% |
| FY2020 | Aug 31, 2020 | 21M | +17.6% |
| FY2019 | Aug 31, 2019 | 17M | +17.3% |
| FY2018 | Aug 31, 2018 | 15M | +11.8% |
| FY2017 | Aug 31, 2017 | 13M | +5.4% |
| FY2016 | Aug 31, 2016 | 13M | +16.7% |
| FY2015 | Aug 31, 2015 | 11M | +17.1% |
| FY2014 | Aug 31, 2014 | 9M | +28.2% |
| FY2013 | Aug 31, 2013 | 7M | +22.5% |
| FY2012 | Aug 31, 2012 | 6M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | 43M | -0.3% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | 42M | +1.8% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | 41M | +0.0% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | 43M | +4.6% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | 43M | +2.4% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | 41M | -0.8% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | 41M | -1.9% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | 41M | +1.1% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | 42M | +3.4% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | 42M | +3.8% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | 42M | +25.2% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | 40M | +35.1% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | 40M | +49.0% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | 40M | +68.6% |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | 33M | +40.3% |
| Q3 FY2021CQ2 2021 | May 31, 2021 | 30M | +28.9% |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | 27M | +51.6% |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | 24M | +36.0% |
| Q4 FY2020CQ3 2020 | Aug 31, 2020 | 24M | +35.4% |
| Q3 FY2020CQ2 2020 | May 31, 2020 | 23M | +33.0% |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | 18M | +9.2% |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | 17M | +20.3% |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | 17M | +20.9% |
| Q3 FY2019CQ2 2019 | May 31, 2019 | 17M | +22.6% |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | 16M | +21.4% |
| Q3 FY2018CQ2 2018 | May 31, 2018 | 15M | +9.2% |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | 14M | +8.8% |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | 14M | +7.8% |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | 13M | +2.3% |
| Q3 FY2017CQ2 2017 | May 31, 2017 | 13M | +1.4% |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | 13M | +5.0% |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | 13M | +14.1% |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | 13M | +14.5% |
| Q3 FY2016CQ2 2016 | May 31, 2016 | 13M | +21.2% |
| Q2 FY2016CQ1 2016 | Feb 29, 2016 | 13M | +16.9% |
| Q1 FY2016CQ4 2015 | Nov 30, 2015 | 12M | – |
| Q4 FY2015CQ3 2015 | Aug 31, 2015 | 11M | – |
| Q3 FY2015CQ2 2015 | May 31, 2015 | 11M | – |
| Q2 FY2015CQ1 2015 | Feb 28, 2015 | 11M | – |
See a number that looks wrong?